GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Innovative MedTech Inc (OTCPK:IMTH) » Definitions » Enterprise Value

IMTH (Innovative MedTech) Enterprise Value : $23.91 Mil (As of Apr. 11, 2025)


View and export this data going back to 2007. Start your Free Trial

What is Innovative MedTech Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Innovative MedTech's Enterprise Value is $23.91 Mil. Innovative MedTech's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $-9.40 Mil. Therefore, Innovative MedTech's EV-to-EBIT ratio for today is -2.55.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Innovative MedTech's Enterprise Value is $23.91 Mil. Innovative MedTech's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was $-9.38 Mil. Therefore, Innovative MedTech's EV-to-EBITDA ratio for today is -2.55.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Innovative MedTech's Enterprise Value is $23.91 Mil. Innovative MedTech's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was $1.34 Mil. Therefore, Innovative MedTech's EV-to-Revenue ratio for today is 17.86.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Innovative MedTech's Enterprise Value is $23.91 Mil. Innovative MedTech's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.05 Mil. Therefore, Innovative MedTech's EV-to-FCF ratio for today is -459.87.


Innovative MedTech Enterprise Value Historical Data

The historical data trend for Innovative MedTech's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovative MedTech Enterprise Value Chart

Innovative MedTech Annual Data
Trend Oct10 Oct11 Oct12 Oct13 Oct14 Jun20 Jun21 Jun22 Jun23 Jun24
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.45 22.80 75.88 13.66 11.63

Innovative MedTech Quarterly Data
Oct14 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.06 13.96 11.63 10.38 22.93

Competitive Comparison of Innovative MedTech's Enterprise Value

For the Medical Instruments & Supplies subindustry, Innovative MedTech's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innovative MedTech's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Innovative MedTech's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Innovative MedTech's Enterprise Value falls into.


;
;

Innovative MedTech Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Innovative MedTech's Enterprise Value for the fiscal year that ended in Jun. 2024 is calculated as

Innovative MedTech's Enterprise Value for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innovative MedTech  (OTCPK:IMTH) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Innovative MedTech's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=23.913/-9.395
=-2.55

Innovative MedTech's current Enterprise Value is $23.91 Mil.
Innovative MedTech's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.40 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Innovative MedTech's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=23.913/-9.377
=-2.55

Innovative MedTech's current Enterprise Value is $23.91 Mil.
Innovative MedTech's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.38 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Innovative MedTech's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=23.913/1.339
=17.86

Innovative MedTech's current Enterprise Value is $23.91 Mil.
Innovative MedTech's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.34 Mil.

4. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Innovative MedTech's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=23.913/-0.052
=-459.87

Innovative MedTech's current Enterprise Value is $23.91 Mil.
Innovative MedTech's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innovative MedTech Enterprise Value Related Terms

Thank you for viewing the detailed overview of Innovative MedTech's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovative MedTech Business Description

Traded in Other Exchanges
N/A
Address
2310 York Street, Suite 200, Blue Island, IL, USA, 60406
Innovative MedTech Inc is a provider of health and wellness services. It develops, manufactures, and sells a variety of medical devices and supplies, including blood collection and infusion products, surgical instruments, and wound care products. The company operates in two divisions: technology and devices and Adult Day Services.
Executives
Merle Griff officer: Chief Executive Officer 2310 YORK ST, SUITE 200, BLUE ISLAND IL 60406
Eddie Dovner 10 percent owner 70 SE 4TH AVE, DELRAY BEACH FL 33483
Charles Everhardt director, 10 percent owner, other: Chairman of the Board 2310 YORK ST, STE 200, BLUE ISLAND IL 60406
Arthur Friedman 10 percent owner 280 MADISON AVE #1007, NEW YORK NY 10016
Marcia Roberts 10 percent owner 280 MADISON AVENUE, SUITE 1005, NEW YORK NY 10016
Michael Jordan Friedman director, 10 percent owner, officer: President & CEO 280 MADISON AVENUE, SUITE 1005, NEW YORK NY 10016
Illuminate, Inc. 10 percent owner 881 KENNEDY BLVD., JERSEY CITL NJ 07002
A William Bodine director, officer: CFO 280 MADISON AVENUE, SUITE 1005, NEW YORK NY 10016
Dominick M Cingari director, officer: COO 280 MADISON AVENUE, SUITE 1005, NEW YORK NY 10016
Jay Odintz director 280 MADISON AVENUE, NEW YORK NY 10016
Vincent L Verdiramo director, officer: President 3163 KENNEDY BLVD, JERSEY CITY NJ 07306